Wealth Enhancement Advisory Services’s Biogen BIIB Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.7M | Buy |
27,867
+8,818
| +46% | +$1.17M | 0.01% | 1040 |
|
|
2025
Q1 | $2.61M | Buy |
19,049
+2,606
| +16% | +$357K | 0.01% | 1109 |
|
|
2024
Q4 | $2.51M | Buy |
16,443
+11,504
| +233% | +$1.76M | ﹤0.01% | 1058 |
|
|
2024
Q3 | $957K | Sell |
4,939
-1,183
| -19% | -$229K | ﹤0.01% | 1419 |
|
|
2024
Q2 | $1.42M | Buy |
6,122
+64
| +1% | +$14.8K | ﹤0.01% | 1132 |
|
|
2024
Q1 | $1.31M | Sell |
6,058
-433
| -7% | -$93.4K | ﹤0.01% | 1118 |
|
|
2023
Q4 | $1.68M | Sell |
6,491
-5,520
| -46% | -$1.43M | ﹤0.01% | 958 |
|
|
2023
Q3 | $3.09M | Buy |
+12,011
| New | +$3.09M | 0.01% | 704 |
|
|
2023
Q2 | – | Sell |
-5,164
| Closed | -$1.44M | – | 516 |
|
|
2023
Q1 | $1.44M | Buy |
+5,164
| New | +$1.44M | 0.02% | 262 |
|
|
2021
Q2 | – | Sell |
-4,048
| Closed | -$1.1M | – | 268 |
|
|
2021
Q1 | $1.1M | Buy |
4,048
+229
| +6% | +$62.2K | 0.02% | 186 |
|
|
2020
Q4 | $1.05M | Buy |
+3,819
| New | +$1.05M | 0.02% | 156 |
|
|
2019
Q2 | – | Sell |
-3,342
| Closed | -$769K | – | 205 |
|
|
2019
Q1 | $769K | Sell |
3,342
-705
| -17% | -$162K | 0.04% | 154 |
|
|
2018
Q4 | $1.37M | Buy |
+4,047
| New | +$1.37M | 0.09% | 89 |
|
|
2018
Q3 | – | Sell |
-3,812
| Closed | -$1.32M | – | 172 |
|
|
2018
Q2 | $1.32M | Buy |
+3,812
| New | +$1.32M | 0.08% | 91 |
|
|
2017
Q3 | – | Sell |
-2,767
| Closed | -$756K | – | 144 |
|
|
2017
Q2 | $756K | Buy |
+2,767
| New | +$756K | 0.07% | 134 |
|